Symbols / ADTX $1.55 -4.31%
ADTX Chart
About
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 344.12K |
| Enterprise Value | 4.50M | Income | -42.24M | Sales | 5.95K |
| Book/sh | -151.87 | Cash/sh | 2.33 | Dividend Yield | — |
| Payout | 0.00% | Employees | 26 | IPO | — |
| P/E | — | Forward P/E | -0.14 | PEG | — |
| P/S | 57.88 | P/B | -0.01 | P/C | — |
| EV/EBITDA | -0.22 | EV/Sales | 756.57 | Quick Ratio | 0.02 |
| Current Ratio | 0.02 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -6637.20 | EPS next Y | -11.29 | EPS Growth | — |
| Revenue Growth | -89.10% | Earnings | 2023-11-14 17:00 | ROA | -61.70% |
| ROE | — | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -4198.70% | Profit Margin | 0.00% | Shs Outstand | 222.00K |
| Shs Float | 63.77K | Short Float | 4.04% | Short Ratio | 0.40 |
| Short Interest | — | 52W High | 11679.68 | 52W Low | 1.52 |
| Beta | 1.17 | Avg Volume | 214.97K | Volume | 78.20K |
| Target Price | — | Recom | None | Prev Close | $1.62 |
| Price | $1.55 | Change | -4.31% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.62
Latest analyst target
3. DCF / Fair value
$-790.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.62
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-09-06 | main | HC Wainwright & Co. | Buy → Buy | $61 |
- $ADTX stock is down 35% today. Here's what we see in our data. - Quiver Quantitative Fri, 13 Mar 2026 14
- Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan Fri, 13 Mar 2026 12
- Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down - MSN Mon, 16 Mar 2026 21
- Aditxt (ADTX) Acquires Ignite Proteomics in $36M Stock Deal - GuruFocus Fri, 13 Mar 2026 13
- 12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga Fri, 13 Mar 2026 17
- Aditxt Buys Ignite Proteomics for $36M in Preferred Stock and Secures $2.88M Note Financing - TradingView Fri, 13 Mar 2026 12
- Aditxt Implements Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail Fri, 06 Mar 2026 08
- Market Movers | Winners: RVPH, DCOY, ADTX | Losers: RBOT, OLMA, BNAI - Trefis ue, 10 Mar 2026 03
- ADTX Stock Shows Energetic Gains as New Financial Strategies Emerge - StocksToTrade Wed, 21 Jan 2026 08
- Eight Aditxt shares become one as 1-for-8 Nasdaq reverse split starts March 9 - Stock Titan hu, 05 Mar 2026 08
- Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus - TipRanks Fri, 13 Mar 2026 12
- Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025 - TechStock² Wed, 17 Dec 2025 08
- Aditxt announces 1-for-8 reverse stock split - MSN ue, 17 Mar 2026 02
- $ADTX stock is up 16% today. Here's what we see in our data. - Quiver Quantitative Fri, 16 Jan 2026 08
- Aditxt Stock Plummets -55% With 7-Day Losing Streak - Trefis Sat, 22 Nov 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | — | Sale at price 1.75 per share. | BRADY BRIAN MICHAEL | Director | — | 2025-12-17 00:00:00 | D |
| 1 | 1 | 3 | — | Sale at price 2.63 per share. | PANKOVCIN CORINNE D | Officer | — | 2025-11-25 00:00:00 | D |
| 2 | 25534 | 29875 | — | Sale at price 1.17 per share. | HRT FINANCIAL L.P | Beneficial Owner of more than 10% of a Class of Security | — | 2024-10-16 00:00:00 | D |
| 3 | 15636 | 23454 | — | Purchase at price 1.50 per share. | HRT FINANCIAL L.P | Beneficial Owner of more than 10% of a Class of Security | — | 2024-10-15 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -27.45M | -25.46M | -24.28M | -26.96M |
| TotalUnusualItems | 414.50K | 0.00 | -543.94K | -17.00M |
| TotalUnusualItemsExcludingGoodwill | 414.50K | 0.00 | -543.94K | -17.00M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -34.45M | -32.38M | -27.65M | -46.37M |
| ReconciledDepreciation | 617.25K | 542.58K | 535.98K | 476.24K |
| ReconciledCostOfRevenue | 627.47K | 756.84K | 766.78K | 77.98K |
| EBITDA | -27.04M | -25.46M | -24.83M | -43.96M |
| EBIT | -27.66M | -26.00M | -25.36M | -44.43M |
| NetInterestIncome | -7.36M | -6.38M | -2.23M | -1.94M |
| InterestExpense | 7.36M | 6.39M | 2.29M | 1.94M |
| InterestIncome | 1.45K | 10.17K | 57.35K | 3.10K |
| NormalizedIncome | -34.86M | -32.38M | -27.11M | -29.37M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -34.45M | -32.38M | -27.65M | -46.37M |
| TotalExpenses | 28.00M | 26.71M | 25.87M | 27.54M |
| TotalOperatingIncomeAsReported | -27.86M | -26.06M | -25.48M | -41.93M |
| DilutedAverageShares | 129.68K | 131.00 | 10.00 | 2.00 |
| BasicAverageShares | 129.68K | 131.00 | 10.00 | 2.00 |
| DilutedEPS | -311.18 | -249.62K | -2.77M | -23.19M |
| BasicEPS | -311.18 | -249.62K | -2.77M | -23.19M |
| DilutedNIAvailtoComStockholders | -40.35M | -32.70M | -27.69M | -46.37M |
| NetIncomeCommonStockholders | -40.35M | -32.70M | -27.69M | -46.37M |
| OtherunderPreferredStockDividend | 5.91M | 319.87K | 37.67K | |
| NetIncome | -34.45M | -32.38M | -27.65M | -46.37M |
| MinorityInterests | 573.57K | 9.61K | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -35.02M | -32.39M | -27.65M | -46.37M |
| NetIncomeContinuousOperations | -35.02M | -32.39M | -27.65M | -46.37M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -35.02M | -32.39M | -27.65M | -46.37M |
| OtherIncomeExpense | 205.83K | 51.71K | -484.98K | -17.00M |
| OtherNonOperatingIncomeExpenses | -208.67K | 51.71K | 58.96K | |
| SpecialIncomeCharges | 0.00 | -543.94K | -17.00M | |
| OtherSpecialCharges | 2.50M | |||
| WriteOff | 0.00 | 543.94K | 14.50M | |
| GainOnSaleOfSecurity | 414.50K | 51.71K | ||
| NetNonOperatingInterestIncomeExpense | -7.36M | -6.38M | -2.23M | -1.94M |
| InterestExpenseNonOperating | 7.36M | 6.39M | 2.29M | 1.94M |
| InterestIncomeNonOperating | 1.45K | 10.17K | 57.35K | 3.10K |
| OperatingIncome | -27.86M | -26.06M | -24.94M | -27.43M |
| OperatingExpense | 27.37M | 25.95M | 25.10M | 27.46M |
| ResearchAndDevelopment | 10.89M | 7.07M | 7.27M | 5.04M |
| SellingGeneralAndAdministration | 16.48M | 18.88M | 17.84M | 22.42M |
| SellingAndMarketingExpense | 197.86K | 269.28K | 1.85M | 334.98K |
| GeneralAndAdministrativeExpense | 16.29M | 18.61M | 15.99M | 22.08M |
| OtherGandA | 16.29M | 18.61M | 15.99M | 22.08M |
| GrossProfit | -493.49K | -111.66K | 166.94K | 27.05K |
| CostOfRevenue | 627.47K | 756.84K | 766.78K | 77.98K |
| TotalRevenue | 133.99K | 645.18K | 933.72K | 105.03K |
| OperatingRevenue | 133.99K | 645.18K | 933.72K | 105.03K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 1.00 | 0.00 | 0.00 | 0.00 |
| OrdinarySharesNumber | 129.68K | 131.00 | 10.00 | 2.00 |
| ShareIssued | 129.68K | 131.00 | 10.00 | 2.00 |
| NetDebt | 4.97M | 16.08M | ||
| TotalDebt | 6.92M | 18.22M | 3.38M | 4.72M |
| TangibleBookValue | 490.44K | 16.05M | 5.10M | 9.97M |
| InvestedCapital | 6.30M | 32.23M | 5.62M | 10.99M |
| WorkingCapital | -21.41M | -18.98M | 1.10M | 5.81M |
| NetTangibleAssets | 8.86M | 16.05M | 5.10M | 9.97M |
| CapitalLeaseObligations | 1.12M | 2.04M | 2.97M | 3.91M |
| CommonStockEquity | 496.55K | 16.06M | 5.21M | 10.18M |
| PreferredStockEquity | 8.37M | 25.00 | ||
| TotalCapitalization | 8.87M | 16.06M | 5.21M | 10.29M |
| TotalEquityGrossMinorityInterest | 8.29M | 16.05M | 5.21M | 10.18M |
| MinorityInterest | -583.18K | -9.61K | 0.00 | |
| StockholdersEquity | 8.87M | 16.06M | 5.21M | 10.18M |
| TreasuryStock | 201.60K | 201.60K | 201.60K | 201.60K |
| RetainedEarnings | -168.09M | -127.74M | -95.04M | -67.35M |
| AdditionalPaidInCapital | 168.79M | 144.00M | 100.45M | 77.73M |
| CapitalStock | 8.37M | 36.00 | 108.00 | 899.00 |
| CommonStock | 130.00 | 11.00 | 108.00 | 899.00 |
| PreferredStock | 8.37M | 25.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 23.86M | 28.53M | 5.53M | 6.48M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 450.87K | 2.64M | 1.89M | 2.88M |
| OtherNonCurrentLiabilities | 1.60M | |||
| DerivativeProductLiabilities | 14.52K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 436.35K | 1.04M | 1.89M | 2.88M |
| LongTermCapitalLeaseObligation | 436.35K | 1.04M | 1.89M | 2.77M |
| LongTermDebt | 110.04K | |||
| CurrentLiabilities | 23.41M | 25.89M | 3.64M | 3.61M |
| OtherCurrentLiabilities | 1.35M | |||
| CurrentDeferredLiabilities | 106.08K | 158.61K | 188.58K | 186.06K |
| CurrentDebtAndCapitalLeaseObligation | 6.48M | 17.18M | 1.50M | 1.85M |
| CurrentCapitalLeaseObligation | 683.35K | 999.94K | 1.09M | 1.15M |
| CurrentDebt | 5.80M | 16.18M | 409.98K | 700.43K |
| OtherCurrentBorrowings | 147.82K | 147.82K | 409.98K | 700.43K |
| CurrentNotesPayable | 5.65M | 16.03M | 0.00 | |
| PayablesAndAccruedExpenses | 15.46M | 8.55M | 1.96M | 1.58M |
| CurrentAccruedExpenses | 3.02M | 1.03M | ||
| InterestPayable | 1.89M | 387.69K | ||
| Payables | 12.44M | 7.52M | ||
| OtherPayable | 2.25M | |||
| AccountsPayable | 10.19M | 7.52M | ||
| TotalAssets | 32.14M | 44.58M | 10.74M | 16.66M |
| TotalNonCurrentAssets | 30.14M | 37.67M | 5.99M | 7.25M |
| OtherNonCurrentAssets | 289.54K | |||
| NonCurrentPrepaidAssets | 87.67K | 11.28M | 355.37K | 379.25K |
| NonCurrentDeferredAssets | 0.00 | 50.00K | 0.00 | |
| InvestmentsAndAdvances | 27.28M | 22.28M | 0.00 | |
| LongTermEquityInvestment | 27.28M | 22.28M | 0.00 | |
| InvestmentsinSubsidiariesatCost | 27.28M | 22.28M | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 6.11K | 9.44K | 107.00K | 214.00K |
| OtherIntangibleAssets | 6.11K | 9.44K | 107.00K | 214.00K |
| NetPPE | 2.77M | 4.10M | 5.48M | 6.36M |
| AccumulatedDepreciation | -1.84M | -1.25M | -815.99K | -387.01K |
| GrossPPE | 4.62M | 5.35M | 6.30M | 6.75M |
| Leases | 120.44K | 120.44K | 120.44K | |
| OtherProperties | 4.06M | 4.79M | 2.58M | 6.35M |
| MachineryFurnitureEquipment | 435.14K | 435.14K | 433.08K | 403.25K |
| BuildingsAndImprovements | 2.20M | 3.16M | ||
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 2.00M | 6.91M | 4.74M | 9.42M |
| PrepaidAssets | 3.38K | 217.39K | 496.87K | 460.10K |
| Inventory | 11.24K | 745.50K | 950.09K | 494.70K |
| RawMaterials | 950.09K | 494.70K | ||
| Receivables | 1.15M | 5.85M | 527.96K | 589.84K |
| OtherReceivables | 1.11M | 5.44M | ||
| NotesReceivable | 0.00 | 500.00K | ||
| AccountsReceivable | 43.44K | 408.33K | 527.96K | 89.84K |
| AllowanceForDoubtfulAccountsReceivable | -4.00K | 0.00 | -18.63K | |
| GrossAccountsReceivable | 47.44K | 408.33K | 546.60K | |
| CashCashEquivalentsAndShortTermInvestments | 833.03K | 97.10K | 2.77M | 7.87M |
| CashAndCashEquivalents | 833.03K | 97.10K | 2.77M | 7.87M |
| CashFinancial | 833.03K | 97.10K | 2.77M | 7.87M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -16.76M | -19.22M | -22.76M | -23.29M |
| RepurchaseOfCapitalStock | -2.85M | -1.00K | -20.00K | 0.00 |
| RepaymentOfDebt | -6.01M | -3.84M | -3.29M | -914.77K |
| IssuanceOfDebt | 4.62M | 9.59M | 2.88M | 4.47M |
| IssuanceOfCapitalStock | 21.17M | 11.06M | 17.25M | 29.87M |
| CapitalExpenditure | -14.41K | -367.08K | -1.02M | |
| InterestPaidSupplementalData | 1.24M | 3.07M | 753.04K | 15.79K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 833.03K | 97.10K | 2.77M | 7.87M |
| BeginningCashPosition | 97.10K | 2.77M | 7.87M | 10.50M |
| ChangesInCash | 735.93K | -2.67M | -5.10M | -2.63M |
| FinancingCashFlow | 22.50M | 16.55M | 17.53M | 35.95M |
| CashFlowFromContinuingFinancingActivities | 22.50M | 16.55M | 17.53M | 35.95M |
| NetOtherFinancingCharges | 4.34M | -261.16K | -400.49K | -1.20M |
| ProceedsFromStockOptionExercised | 1.25M | 0.00 | 1.11M | 3.73M |
| NetPreferredStockIssuance | -2.85M | 0.00 | 0.00 | 0.00 |
| PreferredStockPayments | -2.85M | -1.00K | -20.00K | 0.00 |
| PreferredStockIssuance | 0.00 | 1.00K | 20.00K | 0.00 |
| NetCommonStockIssuance | 21.17M | 11.05M | 17.23M | 29.87M |
| CommonStockIssuance | 21.17M | 11.05M | 17.23M | 29.87M |
| NetIssuancePaymentsOfDebt | -1.40M | 5.75M | -411.89K | 3.56M |
| NetShortTermDebtIssuance | -1.40M | 5.75M | -411.89K | -315.79K |
| ShortTermDebtPayments | -6.01M | -3.84M | -3.29M | -315.79K |
| ShortTermDebtIssuance | 4.62M | 9.59M | 2.88M | |
| NetLongTermDebtIssuance | -812.38K | 3.56M | ||
| LongTermDebtPayments | -3.69M | -914.77K | ||
| LongTermDebtIssuance | 2.88M | 4.47M | ||
| InvestingCashFlow | -5.00M | -14.41K | -241.92K | -16.31M |
| CashFlowFromContinuingInvestingActivities | -5.00M | -14.41K | -241.92K | -16.31M |
| NetOtherInvestingChanges | 125.16K | -15.29M | ||
| NetInvestmentPurchaseAndSale | -5.00M | 0.00 | ||
| PurchaseOfInvestment | -5.00M | 0.00 | ||
| NetPPEPurchaseAndSale | 0.00 | -14.41K | -367.08K | -1.02M |
| PurchaseOfPPE | 0.00 | -14.41K | -367.08K | -1.02M |
| OperatingCashFlow | -16.76M | -19.20M | -22.39M | -22.28M |
| CashFlowFromContinuingOperatingActivities | -16.76M | -19.20M | -22.39M | -22.28M |
| ChangeInWorkingCapital | 7.09M | 9.10M | -493.44K | 129.97K |
| ChangeInOtherCurrentLiabilities | 667.00K | 1.60M | 0.00 | |
| ChangeInPayablesAndAccruedExpense | 5.10M | 6.65M | 412.96K | 1.33M |
| ChangeInPrepaidAssets | 232.75K | 528.43K | -12.88K | -396.80K |
| ChangeInInventory | 734.26K | 204.59K | -455.40K | -494.70K |
| ChangeInReceivables | 364.89K | 119.64K | -438.12K | -312.46K |
| ChangesInAccountReceivables | 364.89K | 119.64K | -438.12K | -312.46K |
| OtherNonCashItems | 4.21M | 2.14M | 1.53M | 1.85M |
| StockBasedCompensation | 6.75M | 1.40M | 3.13M | 4.64M |
| AssetImpairmentCharge | 0.00 | 543.94K | 14.50M | |
| DepreciationAmortizationDepletion | 617.25K | 542.58K | 535.98K | 476.24K |
| DepreciationAndAmortization | 617.25K | 542.58K | 535.98K | 476.24K |
| AmortizationCashFlow | 3.33K | 107.56K | 107.00K | 107.00K |
| AmortizationOfIntangibles | 3.33K | 107.56K | 107.00K | 107.00K |
| Depreciation | 613.92K | 435.03K | 428.98K | 369.24K |
| OperatingGainsLosses | -411.50K | 6.98K | 2.50M | |
| GainLossOnInvestmentSecurities | -414.50K | |||
| GainLossOnSaleOfPPE | 3.00K | 0.00 | 6.98K | 0.00 |
| NetIncomeFromContinuingOperations | -35.02M | -32.39M | -27.65M | -46.37M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ADTX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|